VISTAGEN THERAPEUTICS, INC. Proceeds from Common Stock Issued
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Proceeds from Common Stock Issued of $928.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2026-08-14
- VISTAGEN THERAPEUTICS, INC. proceeds from issuance of common stock for the quarter ending 2026-06-30 was $928.00K, a 133.75% increase year-over-year.
- VISTAGEN THERAPEUTICS, INC. proceeds from issuance of common stock for the quarter ending 2025-12-31 was $2.31M, a 118.62% increase year-over-year.
- VISTAGEN THERAPEUTICS, INC. proceeds from issuance of common stock for the quarter ending 2025-09-30 was $27.93M.
- VISTAGEN THERAPEUTICS, INC. proceeds from issuance of common stock for the quarter ending 2025-06-30 was $397.00K.
- VISTAGEN THERAPEUTICS, INC. proceeds from issuance of common stock for fiscal 2021 was $12.96M, a 286.92% increase from fiscal 2020.
- VISTAGEN THERAPEUTICS, INC. proceeds from issuance of common stock for fiscal 2020 was $3.35M, a 80.35% decline from fiscal 2019.
- VISTAGEN THERAPEUTICS, INC. proceeds from issuance of common stock for fiscal 2019 was $17.04M, a 1.91% increase from fiscal 2018.
- VISTAGEN THERAPEUTICS, INC. proceeds from issuance of common stock for fiscal 2018 was $16.72M, a 68.92% increase from fiscal 2017.
| Period end | Proceeds from Issuance of Common Stock | Proceeds from Issuance of Common Stock 1 month | Proceeds from Issuance of Common Stock 1 month as first filed | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 3 month as first filed | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 6 month as first filed | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 9 month as first filed | Proceeds from Issuance of Common Stock 10 month | Proceeds from Issuance of Common Stock 12 month | Proceeds from Issuance of Common Stock 157 month | Proceeds from Issuance of Common Stock 160 month | Proceeds from Issuance of Common Stock 163 month | Proceeds from Issuance of Common Stock 166 month | Proceeds from Issuance of Common Stock 169 month | Proceeds from Issuance of Common Stock 172 month | Proceeds from Issuance of Common Stock 175 month | Proceeds from Issuance of Common Stock 178 month | Proceeds from Issuance of Common Stock 181 month | Proceeds from Issuance of Common Stock 184 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $928.00K 10-Q · filed 2026-08-14 | ||||||||||||||||||||
| 2025-12-31 | $2.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-12 | $30.24M derived: sum of 2 quarters · filed 2026-02-12 | $30.64M 10-Q · filed 2026-02-12 | ||||||||||||||||||
| 2025-09-30 | $27.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-13 | $28.32M 10-Q · filed 2025-11-13 | |||||||||||||||||||
| 2025-06-30 | $397.00K 10-Q · filed 2026-08-14 | ||||||||||||||||||||
| 2024-12-31 | $1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-12 | $1.06M derived: sum of 2 quarters · filed 2026-02-12 | $1.06M 10-Q · filed 2026-02-12 | ||||||||||||||||||
| 2024-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | |||||||||||||||||||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 | ||||||||||||||||||||
| 2023-12-31 | $210.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-13 | $35.17M derived: sum of 2 quarters · filed 2025-02-13 | $36.24M 10-Q · filed 2025-02-13 | ||||||||||||||||||
| 2023-09-30 | $34.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | $36.03M 10-Q · filed 2024-11-07 | |||||||||||||||||||
| 2023-06-30 | $1.07M 10-Q · filed 2024-08-13 | ||||||||||||||||||||
| 2021-06-30 | $44.50K 10-Q · filed 2021-08-12 | $27.40K derived: sum of 2 quarters · filed 2021-08-12 | $41.00K derived: sum of 3 quarters · filed 2021-08-12 | $12.94M derived: sum of 4 quarters · filed 2021-08-12 | |||||||||||||||||
| 2021-03-31 | -$17.10K derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-29 | -$3.50K derived: sum of 2 quarters · filed 2021-06-29 | $12.90M derived: sum of 3 quarters · filed 2021-06-29 | $12.96M 10-K · filed 2021-06-29 | |||||||||||||||||
| 2020-12-31 | $13.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-11 | $12.91M derived: sum of 2 quarters · filed 2021-02-11 | $12.97M 10-Q · filed 2021-02-11 | $15.67M derived: sum of 4 quarters · filed 2021-08-12 | |||||||||||||||||
| 2020-09-30 | $12.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-12 | $12.96M 10-Q · filed 2020-11-12 | $15.66M derived: sum of 3 quarters · filed 2021-08-12 | $16.31M derived: sum of 4 quarters · filed 2021-08-12 | |||||||||||||||||
| 2020-08-31 | $12.50M 10-K · filed 2022-06-23 | ||||||||||||||||||||
| 2020-06-30 | $62.60K 10-Q · filed 2021-08-12 | $2.76M derived: sum of 2 quarters · filed 2021-08-12 | $3.41M derived: sum of 3 quarters · filed 2021-08-12 | $3.41M derived: sum of 4 quarters · filed 2021-08-12 | |||||||||||||||||
| 2020-03-31 | $2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-29 | $3.35M derived: sum of 2 quarters · filed 2021-06-29 | $3.35M derived: sum of 3 quarters · filed 2021-06-29 | $3.35M 10-K · filed 2021-06-29 | |||||||||||||||||
| 2019-12-31 | $650.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-11 | $650.00K derived: sum of 2 quarters · filed 2021-02-11 | $650.00K 10-Q · filed 2021-02-11 | $11.08M derived: sum of 4 quarters · filed 2021-02-11 | |||||||||||||||||
| 2019-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-12 | $0.00 10-Q · filed 2020-11-12 | $10.43M derived: sum of 3 quarters · filed 2020-11-12 | $12.26M derived: sum of 4 quarters · filed 2020-11-12 | |||||||||||||||||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-13 | $10.43M derived: sum of 2 quarters · filed 2020-08-13 | $12.26M derived: sum of 3 quarters · filed 2020-08-13 | $16.98M derived: sum of 4 quarters · filed 2020-08-13 | |||||||||||||||||
| 2019-03-31 | $10.43M derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-29 | $12.26M derived: sum of 2 quarters · filed 2020-06-29 | $16.98M derived: sum of 3 quarters · filed 2020-06-29 | $17.04M 10-K · filed 2020-06-29 | |||||||||||||||||
| 2018-12-31 | $1.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-13 | $6.55M derived: sum of 2 quarters · filed 2020-02-13 | $6.61M 10-Q · filed 2020-02-13 | $6.61M derived: sum of 4 quarters · filed 2020-02-13 | |||||||||||||||||
| 2018-09-30 | $4.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-07 | $4.78M 10-Q · filed 2019-11-07 | $4.78M derived: sum of 3 quarters · filed 2019-11-07 | $18.55M derived: sum of 4 quarters · filed 2019-11-07 | |||||||||||||||||
| 2018-06-30 | $57.50K 10-Q · filed 2019-08-13 | $57.90K derived: sum of 2 quarters · filed 2019-08-13 | $13.83M derived: sum of 3 quarters · filed 2019-08-13 | $15.91M derived: sum of 4 quarters · filed 2019-08-13 | |||||||||||||||||
| 2018-03-31 | $400.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-25 | $13.77M derived: sum of 2 quarters · filed 2019-06-25 | $15.85M derived: sum of 3 quarters · filed 2019-06-25 | $16.72M 10-K · filed 2019-06-25 | |||||||||||||||||
| 2017-12-31 | $13.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-12 | $15.85M derived: sum of 2 quarters · filed 2019-02-12 | $16.72M 10-Q · filed 2019-02-12 | $16.84M derived: sum of 4 quarters · filed 2019-02-12 | |||||||||||||||||
| 2017-09-30 | $2.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-10-29 | $2.95M 10-Q · filed 2018-10-29 | $3.06M derived: sum of 3 quarters · filed 2018-10-29 | $3.31M derived: sum of 4 quarters · filed 2018-10-29 | |||||||||||||||||
| 2017-06-30 | $873.30K 10-Q · filed 2018-08-14 | $987.80K derived: sum of 2 quarters · filed 2018-08-14 | $1.24M derived: sum of 3 quarters · filed 2018-08-14 | $1.24M derived: sum of 4 quarters · filed 2018-08-14 | |||||||||||||||||
| 2017-03-31 | $114.50K derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-26 | $362.40K derived: sum of 2 quarters · filed 2018-06-26 | $362.40K derived: sum of 3 quarters · filed 2018-06-26 | $9.90M 10-K · filed 2018-06-26 | |||||||||||||||||
| 2016-12-31 | $247.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-12 | $247.90K derived: sum of 2 quarters · filed 2018-02-12 | $9.79M 10-Q · filed 2018-02-12 | $9.79M derived: sum of 4 quarters · filed 2018-02-12 | |||||||||||||||||
| 2016-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-09 | $9.54M 10-Q · filed 2017-11-09 | $9.54M derived: sum of 3 quarters · filed 2017-11-09 | $9.54M derived: sum of 4 quarters · filed 2017-11-09 | |||||||||||||||||
| 2016-06-30 | $9.54M 10-Q · filed 2017-08-14 | $9.54M derived: sum of 2 quarters · filed 2017-08-14 | $9.54M derived: sum of 3 quarters · filed 2017-08-14 | $9.54M derived: sum of 4 quarters · filed 2017-08-14 | |||||||||||||||||
| 2016-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-29 | $0.00 derived: sum of 2 quarters · filed 2017-06-29 | $0.00 derived: sum of 3 quarters · filed 2017-06-29 | $5.03M 10-K · filed 2016-06-24 | $280.00K 10-K · filed 2017-06-29 | ||||||||||||||||
| 2015-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-13 | $0.00 derived: sum of 2 quarters · filed 2017-02-13 | $280.00K 10-Q · filed 2017-02-13 | $1.30M derived: sum of 4 quarters · filed 2017-02-13 | |||||||||||||||||
| 2015-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-14 | $280.00K 10-Q · filed 2016-11-14 | $1.30M derived: sum of 3 quarters · filed 2016-11-14 | $1.70M derived: sum of 4 quarters · filed 2016-11-14 | |||||||||||||||||
| 2015-06-30 | $280.00K 10-Q · filed 2016-08-12 | $1.30M derived: sum of 2 quarters · filed 2016-08-12 | $1.70M derived: sum of 3 quarters · filed 2016-08-12 | $1.91M derived: sum of 4 quarters · filed 2016-08-12 | |||||||||||||||||
| 2015-05-14 | $280.00K 10-K · filed 2016-06-24 | ||||||||||||||||||||
| 2015-03-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-24 | $1.42M derived: sum of 2 quarters · filed 2016-06-24 | $1.63M derived: sum of 3 quarters · filed 2016-06-24 | $3.15M 10-K · filed 2016-06-24 | |||||||||||||||||
| 2014-12-31 | $398.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-16 | $608.20K derived: sum of 2 quarters · filed 2016-02-16 | $2.13M 10-Q · filed 2016-02-16 | $2.61M derived: sum of 4 quarters · filed 2016-02-16 | |||||||||||||||||
| 2014-09-30 | $210.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-11-16 | $1.73M 10-Q · filed 2015-11-16 | $2.21M derived: sum of 3 quarters · filed 2015-11-16 | $2.54M derived: sum of 4 quarters · filed 2015-11-16 | |||||||||||||||||
| 2014-08-08 | $36.00M 10-Q · filed 2014-08-12 | ||||||||||||||||||||
| 2014-06-30 | $1.52M 10-Q · filed 2015-08-14 | $2.00M derived: sum of 2 quarters · filed 2015-08-14 | $2.33M derived: sum of 3 quarters · filed 2015-08-14 | $2.54M derived: sum of 4 quarters · filed 2015-08-14 | |||||||||||||||||
| 2014-03-31 | $477.60K derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-29 | $808.20K derived: sum of 2 quarters · filed 2015-06-29 | $1.02M derived: sum of 3 quarters · filed 2015-06-29 | $1.08M 10-K · filed 2015-06-29 | $5.06M 10-K · filed 2014-06-25 | ||||||||||||||||
| 2014-02-04 | $15.00M 10-K · filed 2014-06-25 | $390.00K 10-Q · filed 2014-02-14 | |||||||||||||||||||
| 2013-12-31 | $330.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-17 | $540.90K derived: sum of 2 quarters · filed 2015-02-17 | $597.90K 10-Q · filed 2015-02-17 | $1.30M derived: sum of 4 quarters · filed 2015-02-17 | $4.58M 10-Q · filed 2014-02-14 | ||||||||||||||||
| 2013-09-30 | $210.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-19 | $267.30K 10-Q · filed 2014-11-19 | $971.80K derived: sum of 3 quarters · filed 2014-11-19 | $1.28M derived: sum of 4 quarters · filed 2014-11-19 | $4.25M 10-Q · filed 2013-11-14 | ||||||||||||||||
| 2013-06-30 | $57.00K 10-Q · filed 2014-08-12 | $761.50K derived: sum of 2 quarters · filed 2014-08-12 | $1.07M derived: sum of 3 quarters · filed 2014-08-12 | $4.04M 10-Q · filed 2013-08-14 | |||||||||||||||||
| 2013-03-31 | $704.50K derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-25 | $1.02M derived: sum of 2 quarters · filed 2014-06-25 | $1.19M 10-K · filed 2014-06-25 | $3.99M 10-K · filed 2013-07-18 | |||||||||||||||||
| 2012-12-31 | $310.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-14 | $480.60K 10-Q · filed 2014-02-14 | $3.28M 10-Q · filed 2013-02-14 | ||||||||||||||||||
| 2012-09-30 | $170.00K 10-Q · filed 2013-11-14 | $2.97M 10-Q · filed 2012-11-14 | |||||||||||||||||||
| 2012-06-30 | $2.80M 10-Q · filed 2012-08-14 | ||||||||||||||||||||
| 2012-03-31 | $150.80K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-18 | $462.00K derived: sum of 2 quarters · filed 2013-07-18 | $462.00K derived: sum of 3 quarters · filed 2013-07-18 | $2.68M 10-K · filed 2013-07-18 | $2.80M 10-K · filed 2012-07-02 | ||||||||||||||||
| 2011-12-31 | $311.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-02-14 | $311.20K derived: sum of 2 quarters · filed 2013-02-14 | $2.53M 10-Q · filed 2013-02-14 | $2.53M 10-Q · filed 2012-02-14 | $2.65M 10-Q · filed 2012-02-14 | ||||||||||||||||
| 2011-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-14 | $2.22M 10-Q · filed 2012-11-14 | $2.22M 10-Q · filed 2011-11-14 | $2.34M 10-Q · filed 2011-11-14 | |||||||||||||||||
| 2011-06-30 | $2.22M 10-Q · filed 2012-08-14 | $2.22M 10-Q · filed 2011-08-22 | $2.34M 10-Q · filed 2011-08-22 | ||||||||||||||||||
| 2010-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-14 | $0.00 10-Q · filed 2012-02-14 | |||||||||||||||||||
| 2010-09-30 | $0.00 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |